| 37681274 | Long-term effects of electroconvulsive therapy on brain structure in major depression. | Psychol Med | 2024 |
| 36730612 | Differences in Cognitive Adverse Effects and Seizure Parameters Between Thiopental and Propofol Anesthesia for Electroconvulsive Therapy. | J ECT | 2023 |
| 37635396 | Inflammation-stratified augmentation of vortioxetine with celecoxib: Results from a double-blind, randomized, placebo-controlled trial in major depressive disorder. | J Neurochem | 2023 |
| 37595325 | Biological markers of sex-based differences in major depressive disorder and in antidepressant response. | Eur Neuropsychopharmacol | 2023 |
| 38077040 | Exploring the genetics of lithium response in bipolar disorders. | Res Sq | 2023 |
| 37713549 | Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions. | World Psychiatry | 2023 |
| 37664245 | Longitudinal early epigenomic signatures inform molecular paths of therapy response and remission in depressed patients. | Front Mol Neurosci | 2023 |
| 37796652 | Exploratory Analysis of the Effects of Celecoxib on Cognitive Function in Vortioxetine-Treated Patients With Major Depressive Disorder in the PREDDICT Study: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. | J Clin Psychiatry | 2023 |
| 37516234 | Epigenetic modification related to cognitive changes during a cognitive training intervention in depression. | Prog Neuropsychopharmacol Biol Psychiatry | 2023 |
| 37844592 | Narcissistic dimensions and depressive symptoms in patients across mental disorders in cognitive behavioural therapy and in psychoanalytic interactional therapy in Germany: a prospective cohort study. | Lancet Psychiatry | 2023 |
| 37944561 | Prevalence of COVID-19 and Psychotropic Drug Treatment in Psychiatric In-patients in Germany in 2020: Results from a Nationwide Pilot Survey. | Pharmacopsychiatry | 2023 |
| 37886563 | Lithium Response in Bipolar Disorder is Associated with Focal Adhesion and PI3K-Akt Networks: A Multi-omics Replication Study. | Res Sq | 2023 |
| 37984280 | Cognitive improvement in patients with major depressive disorder after personalised multi domain training in the CERT-D study. | Psychiatry Res | 2023 |
| 37777856 | GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors. | Am J Psychiatry | 2023 |
| 37451594 | Immune gene co-expression signatures implicated in occurence and persistence of cognitive dysfunction in depression. | Prog Neuropsychopharmacol Biol Psychiatry | 2023 |
| 37347392 | Exploratory study of ultraviolet B (UVB) radiation and age of onset of bipolar disorder. | Int J Bipolar Disord | 2023 |
| 37433967 | Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder. | Mol Psychiatry | 2023 |
| 36966169 | Medication adherence and cognitive performance in schizophrenia-spectrum and bipolar disorder: results from the PsyCourse Study. | Transl Psychiatry | 2023 |
| 37331380 | The mediating role of personality traits in the association between childhood trauma and depressive symptoms in young adulthood. | J Affect Disord | 2023 |
| 37461719 | Immunogenetics of lithium response and psychiatric phenotypes in patients with bipolar disorder. | Res Sq | 2023 |
| 37461564 | Genetic structure of major depression symptoms across clinical and community cohorts. | medRxiv | 2023 |
| 36621676 | Association between mitochondria-related genes and cognitive performance in the PsyCourse Study. | J Affect Disord | 2023 |
| 36937716 | Editorial: Precision psychiatry from a pharmacogenetics perspective. | Front Psychiatry | 2023 |
| 36824922 | Association of Polygenic Score and the involvement of Cholinergic and Glutamatergic Pathways with Lithium Treatment Response in Patients with Bipolar Disorder. | Res Sq | 2023 |
| 32921338 | White matter fiber microstructure is associated with prior hospitalizations rather than acute symptomatology in major depressive disorder. | Psychol Med | 2022 |
| 35740262 | Systemic Inflammation Predicts Alzheimer Pathology in Community Samples without Dementia. | Biomedicines | 2022 |
| 35653754 | The role of educational attainment and brain morphology in major depressive disorder: Findings from the ENIGMA major depressive disorder consortium. | J Psychopathol Clin Sci | 2022 |
| 35380222 | [Vagus nerve stimulation for difficult to treat depression]. | Nervenarzt | 2022 |
| 35770420 | Antidepressant prescribing patterns in Australia. | BJPsych Open | 2022 |
| 35505515 | Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach - CORRIGENDUM. | Br J Psychiatry | 2022 |
| 35671641 | Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the art. | Eur Neuropsychopharmacol | 2022 |
| 35436329 | Effect of High-Intensity Power Training on Cognitive Function in Older Adults With Type 2 Diabetes: Secondary Outcomes of the GREAT2DO Study. | J Gerontol A Biol Sci Med Sci | 2022 |
| 35396580 | Mapping genomic loci implicates genes and synaptic biology in schizophrenia. | Nature | 2022 |
| 35492726 | Transdiagnostic Cognitive-Behavioral Therapy for Depression and Anxiety Disorders in Cardiovascular Disease Patients: Results From the CHAMPS Pilot-Feasibility Trial. | Front Psychiatry | 2022 |
| 35526724 | Chemokine receptor 4 expression on blood T lymphocytes predicts severity of major depressive disorder. | J Affect Disord | 2022 |
| 35390698 | Immunological changes following electroconvulsive therapy in multiple sclerosis. | J Psychiatr Res | 2022 |
| 35817769 | Correction: Combining schizophrenia and depression polygenic risk scores improves the genetic prediction of lithium response in bipolar disorder patients. | Transl Psychiatry | 2022 |
| 35561539 | Evaluating study designs and treatment outcomes of antidepressant pharmacogenetic clinical trials - Challenges and future perspectives. A critical review. | Eur Neuropsychopharmacol | 2022 |
| 35712048 | Identifying the Common Genetic Basis of Antidepressant Response. | Biol Psychiatry Glob Open Sci | 2022 |
| 35994863 | Symptom monitoring based on digital data collection during inpatient treatment of schizophrenia spectrum disorders - A feasibility study. | Psychiatry Res | 2022 |
| 35932492 | Association between polarity of first episode and solar insolation in bipolar I disorder. | J Psychosom Res | 2022 |
| 35990050 | Corrigendum: Potential genetic overlap between insomnia and sleep symptoms in major depressive disorder: A polygenic risk score analysis. | Front Psychiatry | 2022 |
| 35896050 | Erratum to "Digital tools for the assessment of pharmacological treatment for depressive disorder: State of the Art. [European Neuropsychopharmacology 60 (2022) 100-116]". | Eur Neuropsychopharmacol | 2022 |
| 36198241 | Corrigendum to 'No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial' [European Neuropsychopharmacology 53 (2021) 34-46]. | Eur Neuropsychopharmacol | 2022 |
| 35895279 | Networks of inflammation, depression, and cognition in aging males and females. | Aging Clin Exp Res | 2022 |
| 36226111 | Expression of CXCR4 on CD4<sup>+</sup> T cells predicts body composition parameters in female adolescents with anorexia nervosa. | Front Psychiatry | 2022 |
| 33684623 | Association Between Genetic Risk for Type 2 Diabetes and Structural Brain Connectivity in Major Depressive Disorder. | Biol Psychiatry Cogn Neurosci Neuroimaging | 2022 |
| 35016057 | Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review. | Eur Neuropsychopharmacol | 2022 |
| 34921380 | Rationale, Mission and Vision for a National Centre of Affective Disorders in Germany. | Pharmacopsychiatry | 2022 |
| 35225756 | Using polygenic scores and clinical data for bipolar disorder patient stratification and lithium response prediction: machine learning approach. | Br J Psychiatry | 2022 |